vs
Side-by-side financial comparison of ACNB CORP (ACNB) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $47.2M, roughly 1.8× ACNB CORP). ACNB CORP runs the higher net margin — 22.9% vs -38.1%, a 61.0% gap on every dollar of revenue. On growth, ACNB CORP posted the faster year-over-year revenue change (42.2% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 22.1%).
ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
ACNB vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $83.1M |
| Net Profit | $10.8M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 27.9% | -4.1% |
| Net Margin | 22.9% | -38.1% |
| Revenue YoY | 42.2% | 20.2% |
| Net Profit YoY | 63.8% | -27.9% |
| EPS (diluted) | $1.10 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $47.2M | $76.4M | ||
| Q3 25 | $50.9M | $83.3M | ||
| Q2 25 | $50.3M | $79.2M | ||
| Q1 25 | $43.5M | $69.2M | ||
| Q4 24 | $33.2M | $68.2M | ||
| Q3 24 | $34.1M | $58.4M | ||
| Q2 24 | $33.3M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $10.8M | $-29.8M | ||
| Q3 25 | $14.9M | $-21.4M | ||
| Q2 25 | $11.6M | $-19.6M | ||
| Q1 25 | $-272.0K | $-24.7M | ||
| Q4 24 | $6.6M | $-18.9M | ||
| Q3 24 | $7.2M | $-21.0M | ||
| Q2 24 | $11.3M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 27.9% | -40.6% | ||
| Q3 25 | 37.2% | -27.8% | ||
| Q2 25 | 29.7% | -28.0% | ||
| Q1 25 | -1.3% | -39.7% | ||
| Q4 24 | 24.8% | -28.9% | ||
| Q3 24 | 27.6% | -38.4% | ||
| Q2 24 | 42.8% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 22.9% | -39.1% | ||
| Q3 25 | 29.2% | -25.7% | ||
| Q2 25 | 23.2% | -24.7% | ||
| Q1 25 | -0.6% | -35.8% | ||
| Q4 24 | 19.9% | -27.6% | ||
| Q3 24 | 21.1% | -35.9% | ||
| Q2 24 | 33.9% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $1.10 | $-0.54 | ||
| Q3 25 | $1.42 | $-0.38 | ||
| Q2 25 | $1.11 | $-0.35 | ||
| Q1 25 | $-0.03 | $-0.45 | ||
| Q4 24 | $0.77 | $-0.34 | ||
| Q3 24 | $0.84 | $-0.40 | ||
| Q2 24 | $1.32 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $245.6M |
| Total DebtLower is stronger | $255.4M | $51.7M |
| Stockholders' EquityBook value | $420.0M | $347.7M |
| Total Assets | $3.2B | $487.1M |
| Debt / EquityLower = less leverage | 0.61× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $65.6M | $286.5M | ||
| Q3 25 | $102.1M | $294.3M | ||
| Q2 25 | $103.1M | $302.7M | ||
| Q1 25 | $123.6M | $316.2M | ||
| Q4 24 | $47.3M | $333.7M | ||
| Q3 24 | $58.1M | $196.8M | ||
| Q2 24 | $86.3M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $255.4M | $51.6M | ||
| Q3 25 | $255.4M | $51.6M | ||
| Q2 25 | $255.4M | $51.5M | ||
| Q1 25 | $255.3M | $51.5M | ||
| Q4 24 | $255.3M | $51.5M | ||
| Q3 24 | $255.3M | $51.4M | ||
| Q2 24 | $255.3M | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $420.0M | $365.9M | ||
| Q3 25 | $408.6M | $380.3M | ||
| Q2 25 | $395.2M | $385.8M | ||
| Q1 25 | $386.9M | $389.2M | ||
| Q4 24 | $303.3M | $402.2M | ||
| Q3 24 | $306.8M | $241.2M | ||
| Q2 24 | $289.3M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $3.2B | $508.1M | ||
| Q3 25 | $3.3B | $511.5M | ||
| Q2 25 | $3.3B | $513.1M | ||
| Q1 25 | $3.3B | $519.4M | ||
| Q4 24 | $2.4B | $534.0M | ||
| Q3 24 | $2.4B | $374.1M | ||
| Q2 24 | $2.5B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.61× | 0.14× | ||
| Q3 25 | 0.62× | 0.14× | ||
| Q2 25 | 0.65× | 0.13× | ||
| Q1 25 | 0.66× | 0.13× | ||
| Q4 24 | 0.84× | 0.13× | ||
| Q3 24 | 0.83× | 0.21× | ||
| Q2 24 | 0.88× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.6M | — |
| Free Cash FlowOCF − Capex | $52.6M | — |
| FCF MarginFCF / Revenue | 111.4% | — |
| Capex IntensityCapex / Revenue | 2.3% | — |
| Cash ConversionOCF / Net Profit | 4.96× | — |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $53.6M | $-10.3M | ||
| Q3 25 | $23.2M | $-6.6M | ||
| Q2 25 | $17.8M | $-15.0M | ||
| Q1 25 | $-71.0K | $-17.0M | ||
| Q4 24 | $39.8M | $-32.4M | ||
| Q3 24 | $13.6M | $-18.8M | ||
| Q2 24 | $9.7M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $52.6M | $-12.2M | ||
| Q3 25 | $22.8M | $-9.5M | ||
| Q2 25 | $17.6M | $-17.8M | ||
| Q1 25 | $-730.0K | $-18.8M | ||
| Q4 24 | $38.8M | $-33.6M | ||
| Q3 24 | $13.3M | $-19.0M | ||
| Q2 24 | $9.4M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 111.4% | -15.9% | ||
| Q3 25 | 44.7% | -11.4% | ||
| Q2 25 | 35.0% | -22.5% | ||
| Q1 25 | -1.7% | -27.2% | ||
| Q4 24 | 117.0% | -49.2% | ||
| Q3 24 | 39.1% | -32.6% | ||
| Q2 24 | 28.3% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 2.3% | 2.4% | ||
| Q3 25 | 0.8% | 3.4% | ||
| Q2 25 | 0.4% | 3.5% | ||
| Q1 25 | 1.5% | 2.7% | ||
| Q4 24 | 2.9% | 1.7% | ||
| Q3 24 | 0.7% | 0.4% | ||
| Q2 24 | 0.9% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.96× | — | ||
| Q3 25 | 1.56× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.03× | — | ||
| Q3 24 | 1.88× | — | ||
| Q2 24 | 0.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACNB
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
